One gram of soft chew, 12 mg of ursolic acid, once a day for 60 days. That was the entire intervention in the first published feline muscle trial, and it moved four of seven mobility scores in the right direction while untreated cats in the same facility went backwards on two others. The fine print matters as much as the headline: 20 cats, a proof-of-concept design, a supplement company behind it, and a control group that got no chew at all.
What the 60-day cat trial actually measured
Ebert and colleagues enrolled 20 domestic shorthair cats at a research facility in South Africa. All had mild to moderate muscle wasting on the WSAVA muscle condition score, a body condition of 3 to 4 on a 5-point scale, and no other disease on examination or bloodwork; all were neutered. Ten cats received one 1 g chew containing 12 mg of ursolic acid each day; ten received nothing.
Mobility was scored 0 to 4 — 4 normal, 3 impaired, 2 more impaired, 1 almost absent, 0 absent — across seven tasks in a 30-minute room with benches and toys, including jumping up 1 m and jumping down 1 m. Three technicians blinded to group scored each cat on days -6 to -2 and again on days 54 to 58.
| Mobility task, scored 0 to 4 | Ursolic acid, 12 mg/day (n=10) | No supplement (n=10) |
|---|---|---|
| Jump to any height | Significant improvement | No significant change |
| Jump up at least 1 m | Significant improvement | No significant change |
| Jump down at least 1 m | Significant improvement | No significant change |
| Play with toys | Significant improvement | No significant change |
| Rise from a resting position | Decline prevented | Significant decline |
| Lie or sit down | Decline prevented | Significant decline |
| Groom | Improved | Improved |
Why a cat can lose muscle at a stable weight
Skeletal muscle is 35 to 40% of a cat's lean mass, and it is the tissue that goes first in ageing, cancer, kidney disease, hyperthyroidism, diabetes and arthritis-related disuse. Fat can replace it, so the scale often says nothing: a 2026 review of feline sarcopenia describes cats that hold their weight while the spine, shoulder blades and hip bones become prominent. Muscle condition scoring — palpating the temporal bones, scapulae, lumbar vertebrae and pelvis — catches that shift before the scale does.
Age also degrades the food itself. Fat digestibility falls in about 10 to 15% of cats aged 8 to 12 and in 30% over 12, reaching as low as 30% against a normal 90%; about 20% of cats past 14 digest less than 77% of dietary protein. In a pilot frailty score of cats aged 11 to 20, 13 of 64 cats judged frail died or were euthanased within six months, against 1 of 54 judged not frail.
What changed inside the muscle
The trial took a 10 mg quadriceps biopsy from each cat on day -1 and another from the opposite leg on day 60, then sequenced the RNA. In treated cats, more than 40 mRNAs that encode mediators of muscle breakdown fell or trended down, and more than 40 that support muscle health rose or trended up. Myostatin, a protein that shrinks muscle, failed to rise the way it did in controls; JAK2, KLF5, TXNIP, FLT1, FRZB and MUSK also fell, while NR4A3, VGLL2, NFATC2, BCL6 and FLNC rose. That is a coherent molecular story, and still a story about recipes rather than tissue: the 10 mg sample was too small for histology or mitochondrial assays, and no imaging measured muscle mass.
Dose, product and what it costs
Dosing is flat, not weight-based: one 1 g bacon-flavoured chew, 12 mg of ursolic acid from sage extract, once daily for cats of any size; a 60-chew tub lasts 60 days. In November 2026 US veterinary retailers listed it at $34.99, with Banfield at $40.24 — about $0.58 a day, or $17.50 a month. An unpublished internal study of 24 cats reportedly gave 0, 12 or 60 mg for 28 days with no adverse effects, so the five-fold margin rests on the sponsor's summary; the label has not been evaluated in pregnant or breeding cats.
The four limits that decide whether to try it
- No placebo chew. Controls got nothing, so handling and the daily treat ritual were not controlled; only the scorers were blinded.
- Uneven groups. Eight males in the treated group against four in controls, matched for age and weight only.
- Small and short. Twenty cats over 60 days; the authors call for larger, randomised, double-blind, placebo-controlled trials that measure muscle mass directly.
- Commercial ties. Virbac funded the work, four authors are Virbac employees, four are Emmyon shareholders, and the ursolic acid patents are licensed to Virbac for cats and dogs.
A 2026 review of feline sarcopenia, written before this trial appeared, found that no supplement had been properly researched or approved for sarcopenic cats and called ursolic acid promising but unproven in cats. This trial is the first feline data, not the last word.
How to run a 60-day test on your own cat
- Day 0: weigh on a scale that reads to 5 g, photograph the spine and hips, and score three tasks.
- Score 0 to 4 for jumping onto a 1 m counter, jumping down from it, and five minutes of toy play; film each so the comparison is honest.
- Repeat at day 30 and day 60. Do not expect the scale to move: treated cats gained 0.30 kg and controls 0.14 kg, a difference the authors did not find significant.
- Stop at day 60 if nothing improved by a full point and the muscle score is unchanged. At $17.50 a month, that is a fair test, not a subscription.
What has to be fixed at the same time
Muscle loss in an older cat is rarely ageing alone. Hyperthyroidism, chronic kidney disease, diabetes, cancer, inflammatory bowel disease and dental pain all drive it, and arthritis stops a cat jumping long before the muscle is visibly gone. A senior diet typically lands at 40 to 50% protein on a dry matter basis, against an AAFCO adult minimum of 26%, and a cat that digests fat poorly needs a palatable, energy-dense food and a feeding plan. Capromorelin is the licensed weight-gain drug for cats with kidney disease; ursolic acid does not replace it, pain control, or treating the primary disease.
Bottom line
If your cat is eight or older with thinning over the spine and hips but a normal weight, 12 mg of ursolic acid daily for 60 days is a cheap, low-risk experiment with one industry-funded trial behind it and endpoints you can score at home. If the wasting comes with vomiting, a ravenous appetite, weight loss or a raised thyroid or kidney value, the supplement is not the next step — the bloodwork is.
This article does not replace veterinary diagnosis. Muscle wasting has treatable causes, and a supplement should follow, not replace, a physical examination and baseline bloodwork.
Terms mentioned in this article
Frequently asked
How much ursolic acid did the cat study use?
One 1 g soft chew containing 12 mg of ursolic acid, given once daily for 60 days to cats of every size. The dose was set by body-surface-area scaling from dog, mouse and human studies rather than by feline weight, so there is no mg/kg figure to calculate at home.
Did the trial prove ursolic acid rebuilds muscle in cats?
No. It measured mRNA changes in a 10 mg muscle biopsy and scored mobility, not muscle mass. There was no placebo chew, the groups were small and unevenly sexed, and the work was funded by the company that sells the chew. It is proof of concept, and the authors ask for randomised placebo-controlled trials.
Is it safe for a cat with kidney disease or hyperthyroidism?
It has not been tested in those cats. The 60-day study excluded cats with concurrent disease, and the unpublished 24-cat tolerance study used healthy animals. Ask your vet first, because weight loss in kidney or thyroid disease needs treatment of the disease, and capromorelin is the licensed appetite and weight drug for CKD.